Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Rhabdomyolysis following clarithromycin monotherapy
Zachary Z. Brener
, Ilya Bilik
, Boris Khorets
, James F. Winchester
, Michael Bergman
Research output
:
Contribution to journal
›
Article
›
peer-review
9
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Rhabdomyolysis following clarithromycin monotherapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Monotherapy
100%
Rhabdomyolysis
100%
Clarithromycin
100%
Myopathy
66%
Potential Adverse Effects
33%
Cytochrome P450 (CYP450)
33%
Metabolism
33%
Statins
33%
Concurrent Use
33%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
33%
Causative Mechanism
33%
Macrolide Antibiotics
33%
Pharmacology, Toxicology and Pharmaceutical Science
Monotherapy
100%
Rhabdomyolysis
100%
Clarithromycin
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
66%
Myopathy
66%
Adverse Event
33%
Cytochrome P450
33%
Antibiotics
33%
Macrolide
33%